New collaboration with Merck-Serono
Nordic Bioscience Clinical Development and Merck-Serono establishes a strategic partnership, where the primarily focus will be on development and execution of a phase II clinical trial program in osteoarthritis to start enrollment in second half of 2013.
Grant from a Danish technology foundation
We are very proud to announce that Nordic Bioscience receives a grant from The Danish National Advanced Technology Foundation to further develop and test ‘The Liver Score’.
